3 learning resources available for this topic
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune connective tissue disorder where the immune system attacks the body's own tissues and organs. It predominantly affects women of childbearing age and can involve multiple organ systems including skin, joints, kidneys, heart, lungs, and nervous system.
SLE results from a complex interplay of genetic predisposition, environmental triggers, and immune system dysfunction leading to loss of self-tolerance. The condition is characterized by the production of autoantibodies, particularly antinuclear antibodies (ANA) and anti-double-stranded DNA antibodies, which form immune complexes that deposit in tissues causing inflammation and organ damage.
Diagnosis requires a combination of clinical features and laboratory findings, with patients typically presenting with a constellation of symptoms including fatigue, joint pain, skin rashes (especially the characteristic malar rash), and systemic manifestations. The fluctuating nature of SLE with periods of flares and remission, combined with its ability to mimic other conditions, makes early recognition and ongoing monitoring crucial for preventing irreversible organ damage, particularly lupus nephritis.